These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21726872)

  • 21. Japanese encephalitis virus production in Vero cells with serum-free medium using a novel oscillating bioreactor.
    Toriniwa H; Komiya T
    Biologicals; 2007 Oct; 35(4):221-6. PubMed ID: 17400474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increasing Vero viable cell densities for yellow fever virus production in stirred-tank bioreactors using serum-free medium.
    Mattos DA; Silva MV; Gaspar LP; Castilho LR
    Vaccine; 2015 Aug; 33(35):4288-91. PubMed ID: 25930117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of cultivation conditions on N-glycosylation of influenza virus a hemagglutinin produced in MDCK cell culture.
    Rödig JV; Rapp E; Bohne J; Kampe M; Kaffka H; Bock A; Genzel Y; Reichl U
    Biotechnol Bioeng; 2013 Jun; 110(6):1691-703. PubMed ID: 23297157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein-free culture of Vero cells: a substrate for replication of human pathogenic viruses.
    Cinatl J; Cinatl J; Rabenau H; Rapp J; Kornhuber B; Doerr HW
    Cell Biol Int; 1993 Sep; 17(9):885-95. PubMed ID: 8220316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production.
    Montomoli E; Khadang B; Piccirella S; Trombetta C; Mennitto E; Manini I; Stanzani V; Lapini G
    Expert Rev Vaccines; 2012 May; 11(5):587-94. PubMed ID: 22827244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation.
    Genzel Y; Dietzsch C; Rapp E; Schwarzer J; Reichl U
    Appl Microbiol Biotechnol; 2010 Sep; 88(2):461-75. PubMed ID: 20617311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification of rabies virus produced in Vero cells grown in serum free medium.
    Trabelsi K; Ben Zakour M; Kallel H
    Vaccine; 2019 Nov; 37(47):7052-7060. PubMed ID: 31300287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suspension-Vero cell cultures as a platform for viral vaccine production.
    Paillet C; Forno G; Kratje R; Etcheverrigaray M
    Vaccine; 2009 Oct; 27(46):6464-7. PubMed ID: 19559123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of MDCK cells for production of live attenuated influenza vaccine.
    Liu J; Shi X; Schwartz R; Kemble G
    Vaccine; 2009 Oct; 27(46):6460-3. PubMed ID: 19559113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Development of a novel influenza vaccine derived from a continuous cell line].
    Kistner O; Barrett N; Mundt W; Reiter M; Schober-Bendixen S; Eder G; Dorner F
    ALTEX; 2001; 18(1):50-4. PubMed ID: 11248852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term stability of Vero cell-derived inactivated Japanese encephalitis vaccine prepared using serum-free medium.
    Toriniwa H; Komiya T
    Vaccine; 2008 Jul; 26(29-30):3680-9. PubMed ID: 18534722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines.
    Hu AY; Weng TC; Tseng YF; Chen YS; Wu CH; Hsiao S; Chou AH; Chao HJ; Gu A; Wu SC; Chong P; Lee MS
    Vaccine; 2008 Oct; 26(45):5736-40. PubMed ID: 18761387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of a serum-free medium for the growth of Vero cells and the production of reovirus.
    Butler M; Burgener A; Patrick M; Berry M; Moffatt D; Huzel N; Barnabé N; Coombs K
    Biotechnol Prog; 2000; 16(5):854-8. PubMed ID: 11027181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous cell lines as a production system for influenza vaccines.
    Genzel Y; Reichl U
    Expert Rev Vaccines; 2009 Dec; 8(12):1681-92. PubMed ID: 19943763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mosquito and mammalian cells grown on microcarriers for four-serotype dengue virus production: variations in virus titer, plaque morphology, and replication rate.
    Liu CC; Wu SC
    Biotechnol Bioeng; 2004 Mar; 85(5):482-8. PubMed ID: 14760688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel mammalian cell (Vero) derived influenza virus vaccine: development, characterization and industrial scale production.
    Kistner O; Barrett PN; Mundt W; Reiter M; Schober-Bendixen S; Eder G; Dorner F
    Wien Klin Wochenschr; 1999 Mar; 111(5):207-14. PubMed ID: 10226351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization and qualification of a quantitative reversed-phase HPLC method for hemagglutinin in influenza preparations and its comparative evaluation with biochemical assays.
    Lorbetskie B; Wang J; Gravel C; Allen C; Walsh M; Rinfret A; Li X; Girard M
    Vaccine; 2011 Apr; 29(18):3377-89. PubMed ID: 21397719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor.
    Rourou S; van der Ark A; Majoul S; Trabelsi K; van der Velden T; Kallel H
    Appl Microbiol Biotechnol; 2009 Nov; 85(1):53-63. PubMed ID: 19521697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of influenza H1N1 vaccine from MDCK cells using a novel disposable packed-bed bioreactor.
    Sun B; Yu X; Kong W; Sun S; Yang P; Zhu C; Zhang H; Wu Y; Chen Y; Shi Y; Zhang X; Jiang C
    Appl Microbiol Biotechnol; 2013 Feb; 97(3):1063-70. PubMed ID: 22945265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification of cell culture-derived influenza A virus via continuous anion exchange chromatography on monoliths.
    Fischer LM; Wolff MW; Reichl U
    Vaccine; 2018 May; 36(22):3153-3160. PubMed ID: 28729020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.